These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6532509)

  • 1. [Establishment of test methods for examining promoters of hepatocarcinogenesis--promoting effects of phenobarbital, butylated hydroxytoluene and barbital].
    Furukawa F; Toyoda K; Kokubo T; Takahashi M; Hayashi Y
    Eisei Shikenjo Hokoku; 1984; (102):71-6. PubMed ID: 6532509
    [No Abstract]   [Full Text] [Related]  

  • 2. Promotion by sodium barbital of renal cortical and transitional cell tumors, but not intestinal tumors, in F344 rats given methyl(acetoxymethyl)nitrosamine, and lack of effect of phenobarbital, amobarbital, or barbituric acid on development of either renal or intestinal tumors.
    Diwan BA; Ohshima M; Rice JM
    Carcinogenesis; 1989 Jan; 10(1):183-8. PubMed ID: 2910521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of liver tumor promoters and structurally related chemicals on survival of normal adult rat hepatocytes in primary culture.
    Miyazaki M; Bai L; Sato J
    J Cancer Res Clin Oncol; 1990; 116(3):259-63. PubMed ID: 2370251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous inhibition of liver carcinogenicity and enhancement of bladder carcinogenicity of N-2-fluorenylacetamide by butylated hydroxytoluene.
    Williams GM; Maeura Y; Weisburger JH
    Cancer Lett; 1983 May; 19(1):55-60. PubMed ID: 6303561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of phenobarbital and butylated hydroxytoluene on the ploidy rate in rat hepatocarcinogenesis.
    Haesen S; Derijcke T; Deleener A; Castelain P; Alexandre H; Préat V; Kirsch-Volders M
    Carcinogenesis; 1988 Oct; 9(10):1755-61. PubMed ID: 3168155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of incomplete carcinogens and promoters in hepatocarcinogenesis.
    Pitot HC; Goldsworthy T; Moran S; Sirica AE; Weeks J
    Carcinog Compr Surv; 1982; 7():85-98. PubMed ID: 6802499
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide.
    Williams GM; Furuya K
    Carcinogenesis; 1984 Feb; 5(2):171-4. PubMed ID: 6697434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enhancement effects of barbital and phenobarbital on aminopyrine-initiated teratogenesis in mice].
    Isa Y; Nomura T
    Yakugaku Zasshi; 1981 May; 101(5):477-81. PubMed ID: 7288589
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative analysis of the effect of phenobarbital, dichlorodiphenyltrichloroethane, butylated hydroxytoluene and nafenopin on rat hepatocarcinogenesis.
    Préat V; de Gerlache J; Lans M; Taper H; Roberfroid M
    Carcinogenesis; 1986 Jun; 7(6):1025-8. PubMed ID: 2871946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotive effects of thiobenzamide on liver carcinogenesis.
    Malvaldi G; Chieli E; Saviozzi M
    Gan; 1983 Aug; 74(4):469-71. PubMed ID: 6628900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. interactions of ionizing radiation, nitrosamines, sulfonoxyalkanes and antioxidants as they affect carcinogenesis and survival in mice.
    Clapp NK
    Am Ind Hyg Assoc J; 1978 Jun; 39(6):448-53. PubMed ID: 210645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of a primary culture of liver cells from rat embryos subjected to transplacental exposure to N-nitrosodiethylamine for the study of hepatocarcinogenesis promoters].
    Kononenko LI; Grabovaia AR; Bykorez AI
    Eksp Onkol; 1987; 9(6):33-6, 70. PubMed ID: 3436288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between species and tissue sensitivity to chemical carcinogenesis in rodents and the induction of DNA synthesis.
    Klaunig JE; Siglin JC; Schafer LD; Hartnett JA; Weghorst CM; Olson MJ; Hampton JA
    Prog Clin Biol Res; 1991; 369():185-94. PubMed ID: 1946517
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification by sodium L-ascorbate, butylated hydroxytoluene, phenobarbital and pepleomycin of lesion development in a wide-spectrum initiation rat model.
    Thamavit W; Fukushima S; Kurata Y; Asamoto M; Ito N
    Cancer Lett; 1989 May; 45(2):93-101. PubMed ID: 2471582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse liver tumors and microsomal enzyme-inducing drugs: experimental and clinical perspectives with phenobarbital.
    McClain RM
    Prog Clin Biol Res; 1990; 331():345-65. PubMed ID: 2156272
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose-dependent enhancing effect of phenobarbital on hepatocarcinogenesis initiated by diethylnitrosamine in the rat.
    Mochizuki Y; Furukawa K; Sawada N; Gotoh M
    Gan; 1981 Feb; 72(1):170-3. PubMed ID: 7274642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotive effects of ethinyl estradiol in hepatocarcinogenesis initiated by diethylnitrosamine in male rats.
    Cameron R; Imaida K; Ito N
    Gan; 1981 Apr; 72(2):339-40. PubMed ID: 7286559
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of the effects of promoting agents on liver and urinary bladder carcinogenesis in rats.
    Ito N; Tatematsu M; Nakanishi K; Tsuda H
    Carcinog Compr Surv; 1982; 7():133-7. PubMed ID: 7066916
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor promoting activities of ethylphenylacetylurea and diethylacetylurea, the ring hydrolysis products of barbiturate tumor promoters phenobarbital and barbital, in rat liver and kidney initiated by N-nitrosodiethylamine.
    Diwan BA; Nims RW; Ward JM; Hu H; Lubet RA; Rice JM
    Carcinogenesis; 1989 Jan; 10(1):189-94. PubMed ID: 2910522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ-specific promoting effect of phenobarbital and saccharin in induction of thyroid, liver, and urinary bladder tumors in rats after initiation with N-nitrosomethylurea.
    Tsuda H; Fukushima S; Imaida K; Kurata Y; Ito N
    Cancer Res; 1983 Jul; 43(7):3292-6. PubMed ID: 6850638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.